Better, earlier and simplified medicine. That’s the goal of every clinician.

Patient assessment is perhaps the most critical step in the treatment of every patient. The assessment  dictates all subsequent patient care decisions. It is in both the patient and care provider’s best interest to  have the most efficient and comprehensive patient assessment tool available. Now you can.

The technology available inWi-Med began with small, wireless monitoring devices developed for the U.S. Navy and Special Forces. This technology has been used successfully in the most remote areas under the harshest conditions and is now available in telemedicine products for all markets.

Wi-Med® is a portable, non-invasive patient assessment system unlike any other.  The Wi-Med® System consists of wireless patient monitoring devices conveniently linked together with patient data stored in a HIPAA compliant secure server.  It is a portable, non-invasive and automated system that quickly and easily collects data never before available in the field and makes this information accessible to physicians and clinicians located anywhere in the world.

Wi-Med® is much more than a telemedicine device. Wi-Med® goes beyond simply allowing clinicians to interface with patients remotely. Wi-Med® gives the provider the tools and information required to make earlier and more informed decisions regarding patient care.

Wi-Med Infographic

Wi-Med® Applications:

  • Comprehensive patient assessments
  • Chronic or acute disease management
  • Telemedicine
  • Continuous Monitoring
  • Monitoring Diuretic therapies in bed-bound pts, or others that cannot be easily weighed
  • Differential diagnosis
  • Fluid Management
  • Fluid Management in dialysis patients
  • Evaluating progressive heart failure
  • Rural Health
  • Home Health (provider present)
  • Community Para-medicine (mobile integrated healthcare)
  • Cost Savings
  • Prevent hospital readmissions
  • Increase access to quality care
  • Assess fluid responsiveness in shock patients
  • Weaning CHF patients off of high-dose beta-blockers and calcium channel/diuretic therapies
  • Titrating to the maximum dose of ACE-I/ARB consistent with renal impairment
  • Adjustment of pacemaker rate settings for maximum cardiac output in marginal patients
  • Titrate hypertensive therapies to the point of maximum cardiac efficiency
  • Evaluate patient with frequent PVCs, AF or other arrhythmia affecting output
  • Evaluate starting or stopping of digoxin therapy
  • Safety in rapid rehydration or transfusion therapy at home
  • Monitoring the terminal patient remotely to aid the family in planning
  • Monitoring patient compliance with dietary restrictions or fluid hydration overnight
  • Use in pharmacologic stress test for IHD evaluations in the bed bound patient
  • Monitoring of pleural effusions over time or during thoracentesis
  • Screening for CHF in patients with poor medical histories and weakness
  • Pre-screening for Cardiac Cath Lab patient priorities
  • Evaluate Cyclosporine or EPO-induced hypertension
  • Short term stabilization of the patient in pulmonary edema